Vitamin E-Engineered Anti-Inflammatory Lipid Nanoparticles for Safer mRNA Delivery
ACS Nano · 07.11.2026
DOI: 10.1021/acsnano.6c17082 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, online erschienen am 07.11.2026. Verfasst von Tingting Song und 19 weiteren Autor:innen. Die Arbeit nennt 37 Literaturangaben. Gefördert von: West China Hospital, Sichuan University, National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Great strides have been achieved in lipid nanoparticle (LNP)-mediated mRNA delivery. However, traditional LNPs can induce undesirable side effects such as inflammatory reactions. Oxidative stress damage arising from ionizable lipids within LNPs is regarded as a major underlying cause of these adverse effects. Herein, we propose incorporating endogenous vitamin E (VE) into the tail moiety of commercial ionizable lipids to improve biosafety. Proof-of-concept investigations using SM-102-derived W3 confirm that this endogenous antioxidant modification substantially mitigates the inflammatory toxicity of mRNA-loaded LNPs. Following intravenous administration, W3 LNPs markedly decrease the levels of multiple pro-inflammatory cytokines, demonstrating an improved safety profile compared to SM-102 LNPs. Further analysis reveals that W3 LNPs significantly reduce intracellular reactive oxygen species (ROS) levels, alleviate oxidative stress damage, thereby inhibiting the activation of key inflammatory pathways such as NF-κB. Of note, the optimized formulation, sW3 LNPs enable efficient mRNA delivery to the spleen, with stronger antitumor efficacy and higher safety than SM-102 LNPs. In summary, W3 lipid confers minimal inflammatory adverse effects while preserving excellent delivery capability, which indicates that the VE-engineered LNPs possess great potential to serve as powerful and multifunctional platforms for next-generation mRNA therapeutics.
Förderung
- West China Hospital, Sichuan University
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Song, T., Zhang, R., Shi, H., Zeng, Y., Duan, X., Zhang, Y., Liu, R., Ruan, X., Du, X., Jiao, X., Jiang, S., Luo, T., Xu, W., Sun, J., Chen, Y., Guo, M., Xie, Y., He, X., Gu, J., & Song, X. (2026). Vitamin E-Engineered Anti-Inflammatory Lipid Nanoparticles for Safer mRNA Delivery. ACS Nano. https://doi.org/10.1021/acsnano.6c17082
Vancouver
Song T, Zhang R, Shi H, Zeng Y, Duan X, Zhang Y, et al. Vitamin E-Engineered Anti-Inflammatory Lipid Nanoparticles for Safer mRNA Delivery. ACS Nano. 2026. doi:10.1021/acsnano.6c17082
BibTeX
@article{Song2026,
author = {Song, Tingting and Zhang, Ruiming and Shi, Haixing and Zeng, Yu and Duan, Xing and Zhang, Yupei and Liu, Ruyue and Ruan, Xuli and Du, Xingjie and Jiao, Xiangyu and Jiang, Shanhui and Luo, Tian and Xu, Weitong and Sun, Ju and Chen, Yuting and Guo, Mengran and Xie, Yongmei and He, Xi and Gu, Jingkai and Song, Xiangrong},
title = {Vitamin E-Engineered Anti-Inflammatory Lipid Nanoparticles for Safer mRNA Delivery},
journal = {ACS Nano},
year = {2026},
doi = {10.1021/acsnano.6c17082}
}
EUVIMED